Literature DB >> 28317767

Empirical and bioinformatic characterization of buffalo (Bubalus bubalis) colostrum whey peptides & their angiotensin I-converting enzyme inhibition.

N R Ashok1, H S Aparna2.   

Abstract

Whey based peptides are well known for their nutritional and multifunctional properties. In this context, whey proteins from buffalo colostrum & milk were digested by in vitro simulation digestion and analyzed by nano-LC-MS/MS. Functional protein association networks, gene annotations and localization of identified proteins were carried out. An ACE inhibitory peptide sorted from the library was custom synthesized and an in vitro ACE assay was performed. The study led to the identification of 74 small peptides which were clustered into 5 gene functional groups and majority of them were secretory proteins. Among the identified peptides, majority of them were found identical to angiotensin I-converting enzyme (ACE) inhibitors, antioxidant, antimicrobial, immunomodulatory and opioidal peptides. An octapeptide (m/z - 902.51, IQKVAGTW) synthesized was found to inhibit ACE with an IC50 of 300±2µM. The present investigation thus establishes newer vista for food derived peptides having ACE inhibitory potential for nutraceutical or therapeutic applications.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Angiotensin I-converting enzyme; Buffalo colostrum; Molecular docking; Nano-LC–MS/MS; Whey peptides

Mesh:

Substances:

Year:  2017        PMID: 28317767     DOI: 10.1016/j.foodchem.2017.02.032

Source DB:  PubMed          Journal:  Food Chem        ISSN: 0308-8146            Impact factor:   7.514


  3 in total

1.  Whey-Derived Peptides Interactions with ACE by Molecular Docking as a Potential Predictive Tool of Natural ACE Inhibitors.

Authors:  Yara Chamata; Kimberly A Watson; Paula Jauregi
Journal:  Int J Mol Sci       Date:  2020-01-29       Impact factor: 5.923

2.  Identification of Potential Peptide Inhibitors of ACE-2 Target of SARS-CoV-2 from Buckwheat & Quinoa.

Authors:  Ashok Nanjaiah Rangaswamy; Arpitha Ashok; Pradeep Hanumanthappa; Aparanji Sinduvalli Chandrashekaramurthy; Monika Kumbaiah; Pratibha Hiregouda; Vaishali Sharma; Aparna Huligerepura Sosalegowda
Journal:  Int J Pept Res Ther       Date:  2021-04-08       Impact factor: 1.931

3.  Milk Peptides as Novel Multi-Targeted Therapeutic Candidates for SARS-CoV2.

Authors:  H Pradeep; Umme Najma; H S Aparna
Journal:  Protein J       Date:  2021-04-11       Impact factor: 2.371

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.